Supporting Innovations in Patient Care

Patients’ needs and safety guide our steps. We are committed to developing and supporting innovations that help healthcare professionals to make informed care decisions. Through investments in technology, clinical decision tools, and research, we work to ensure healthcare professionals have the information they need to thoughtfully address individual patient needs. These efforts include:

Patient-Focused Research Collaboration

  • Supporting innovative research to advance pain care approaches through investigator-led studies focused on developing clinically relevant and useful tools to help evaluate chronic pain. The assessment of pain levels is important in making a correct diagnosis, determining appropriate therapy, and studying responses to treatment.
  • Collaborating with the National Institutes of Health (NIH), as recommended by President Trump’s Opioid Commission, toward the creation of a public-private partnership focused on accelerating the development of treatments for opioid use disorders and non-opioid, non-addictive pain medications.

Medication Safety, Storage, and Disposal

  • Collaborating with the US Conference of Mayors (USCM) to provide awards to cities for the “Safeguard My Meds Prescription Drug Abuse Prevention Recognition Program” to honor outstanding initiatives that address prescription drug misuse and abuse in America’s cities.
  • Partnering with Project Lazarus and Safe Kids North Carolina to support state-wide medicine disposal activities and conduct systematic research to evaluate the impact of community-based prevention programs on opioid-related overdoses, abuse, and diversion.
  • Supporting Risk Evaluation and Mitigation Strategies (REMs), which include patient counseling information.

Clinical Decision Tools

We believe doctors should check their state Prescription Drug Monitoring Program (PDMP) databases before writing a controlled substance prescription, and we encourage prescribers to register and use PDMPs. Evidence shows PDMPs are effective in supporting appropriate clinical decision-making and reducing doctor shopping.

We work to improve information sharing by:

  • Supporting and promoting improved PDMP utility for clinicians such as accessing data across state lines, allowing use by a prescriber’s delegate, and integrating information into the clinical workflow.
  • Improving care coordination through a public-private partnership with the Commonwealth of Virginia. This initiative integrates prescription monitoring program data into the regular workflow of doctors, nurses, and pharmacists.

We also provided $1 million in funding to the National Association of Boards of Pharmacy (NABP) to enable states to connect at no cost to the NABP’s PMPInterConnect® platform and share prescription drug monitoring data with each other. It is now used by more than 40 states.